THERESA BOSANEK: Open Payments
NPI 1467699959 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $383 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| UCB, Inc. | 3 | $80 |
| Medtronic, Inc. | 2 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| CSL Behring | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: KESIMPTA, STEALTHSTATION S8 PLATFORM, BOTOX, Briviact, VYALEV, Nayzilam, Hizentra, HYQVIA.
Industry payments across TX — which companies pay providers there.
